MedTrace Logo

Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer

NCT01717261 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine if partial breast irradiation administered in a single preoperative fraction is tolerable.

Conditions

Interventions

RADIATION

Single Pre-Operative Radiation Therapy

Dose escalation: 3 patients will receive 15 Gy in a single fraction. The following 3 patients will receive 18 Gy. The final 4 patients will receive 20 Gy.

Sponsors & Collaborators

  • Maisonneuve-Rosemont Hospital

    lead OTHER

Principal Investigators

  • Michael Yassa, MD · Maisonneuve-Rosemon Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2018-12-31
Completion
2023-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01717261 on ClinicalTrials.gov